The president indicated that duties on chips would be “approximately 100%” earlier this month.

The investment includes increasing manufacturing and research and development capabilities at its Reedsville, Pennsylvania, ...

The fresh funding will support pivotal trials in progress and commercialization preparations at the two heart-focused ...

Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.

By combining surgical video with other insights, Jegatheeswaran hopes Johnson & Johnson can support better outcomes in ...

Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last ...

Days into the job, CEO Stephen From said the company no longer expects to begin a clinical trial for its robotic system by ...

The records system is available for U.S. ambulatory providers, pending regulatory approval. Oracle plans to launch in the acute care market next year.

Cardiosense has appointed John Martin as chief medical officer. The appointment puts Martin in charge of clinical development and product strategy as the company prepares for commercial launch.

The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid ...